Wells Fargo & Company Cardiovascular Systems Inc Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$13.31 - $19.86 $111,857 - $166,903	8,404 Added 528.22%	9,995 $198,000
Q4 2022 Feb 13, 2023	SELL	$12.74 - $15.12 $15,364 - $18,234	-1,206 Reduced 43.12%	1,591 $21,000
Q3 2022 Nov 14, 2022	SELL	$12.93 - $17.17 $8,262 - $10,971	-639 Reduced 18.6%	2,797 $40,000
Q2 2022 Aug 12, 2022	SELL	$13.53 - $23.34 $265,106 - $457,323	-19,594 Reduced 85.08%	3,436 $50,000
Q1 2022 May 16, 2022	SELL	$16.14 - $22.6 $235,095 - $329,191	-14,566 Reduced 38.74%	23,030 $520,000
Q4 2021 Feb 14, 2022	SELL	$18.64 - $36.77 $649,361 - $1.28 Million	-34,837 Reduced 48.1%	37,596 $707,000
Q3 2021 Nov 15, 2021	BUY	$32.83 - $43.0 $558,996 - $732,161	17,027 Added 30.73%	72,433 $2.38 Million
Q2 2021 Aug 16, 2021	SELL	$34.41 - $44.03 $486,970 - $623,112	-14,152 Reduced 20.35%	55,406 $2.36 Million
Q1 2021 May 13, 2021	SELL	$37.29 - $47.19 $2.46 Million - $3.11 Million	-65,966 Reduced 48.67%	69,558 $2.67 Million
Q4 2020 Feb 09, 2021	SELL	$34.3 - $44.09 $317,446 - $408,052	-9,255 Reduced 6.39%	135,524 $5.93 Million
Q3 2020 Nov 05, 2020	SELL	$27.86 - $39.35 $23,207 - $32,778	-833 Reduced 0.57%	144,779 $5.7 Million
Q2 2020 Aug 13, 2020	BUY	$30.3 - $42.55 $494,314 - $694,160	16,314 Added 12.62%	145,612 $4.59 Million
Q1 2020 May 14, 2020	BUY	$30.0 - $54.18 $3.88 Million - $7.01 Million	129,298 New	129,298 $4.55 Million

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.